Skip to Content

Meet the Health-Care Company IBM Needed to Make Watson More Insightful

With the addition of a huge medical records database—and the computing infrastructure to analyze it—Watson could help doctors make better use of clinical data.
April 16, 2015

IBM could be gaining a crucial tool in its effort to turn its Watson artificial-intelligence technology into a valuable source of medical insights.

IBM has said that one of the most valuable applications of Watson, best known for beating human competitors on Jeopardy!, will be its ability to draw practical knowledge from the analysis of massive stores of digital health-care information (see “IBM Aims to Make Medical Expertise a Commodity”). To get one such enormous database, this week IBM announced it is buying a startup called Explorys, which was spun out of the Cleveland Clinic and owns anonymized records pertaining to more than 50 million people. But the company does more than merely hold the records. Explorys CEO Steve McHale says the startup has computing technologies that can mine databases for insights applicable in many areas of health care, from medical research to direct patient care.

Explorys’s technology runs on Hadoop, a data management system that relies on distributed computer clusters and allows for much faster processing and analysis of large, complicated data sets than conventional database systems can handle. The speed was important in the company’s pilot application, a search engine that gave physicians at the Cleveland Clinic a way to find data in medical records. Explorys has since built analytics tools that perform specific functions like identifying risk factors and common gaps in patient care that can lead to bad outcomes.

The technology has also shown it can vastly speed up medical research. Recently, physicians at the MetroHealth system in Cleveland and Explorys employees used the platform to replicate the results of a study on the prevalence of blood clots in a group of patients. The original study required researchers to follow patients for 14 years; by analyzing medical records that had the same amount of data, the new technology delivered the same findings in just three months.

The health records come from a number of health-care organizations that have agreed to help Explorys aggregate data. McHale says identifying information on the patients has been stripped out.

Watson has been put to work analyzing other sets of medical records, helping hospitals look for billing errors and even giving doctors advice in some pilot programs. Now, McHale says, Explorys should “accelerate” Watson’s progress and lead to analytics tools that wouldn’t be possible otherwise.

Keep Reading

Most Popular

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.